Valuation : Cegedim

Market Cap 142M 164M 134M 122M 228M 15.71B 229M 1.59B 613M 7.99B 618M 604M 25.26B P/E 2026 *
6.77x
P/E 2027 * 5.16x
Enterprise Value 304M 353M 288M 261M 489M 33.69B 492M 3.42B 1.31B 17.14B 1.32B 1.3B 54.16B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 week-0.19%
Current month-0.39%
1 month-0.77%
3 months-8.35%
6 months-1.71%
Current year-23.84%
1 week 10.2
Extreme 10.2
10.6
1 month 10.1
Extreme 10.1
10.6
Current year 8.5
Extreme 8.5
15.3
1 year 8.5
Extreme 8.5
15.3
3 years 8.5
Extreme 8.5
20
5 years 8.5
Extreme 8.5
29.25
10 years 8.5
Extreme 8.5
44.5
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Date Insider Type Main position Quantity % Market Cap. Importance
4/30/26 A Buy 751 0.0053%
4/28/26 A Buy 74,537 0.5287%
4/16/26 A Buy 500 0.0035%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.19%+0.68%-47.88% 165M
-1.74%-5.35%-51.19%+18.60% 441B
-0.31%-4.53%-19.35%+37.52% 239B
+1.04%-6.18%-29.38%+9.36% 136B
+1.87%-8.28%-59.83%+282.19% 49.4B
+2.49%-6.48%-36.17%+0.98% 42.31B
+2.57%+5.70%-38.28%+8.89% 20.75B
+0.56%-5.39%-21.26%+50.66% 18.46B
+1.44%-3.04%-30.40%+13.53% 13.25B
-0.23%-4.03%-18.18%+39.65% 12.3B
Average +0.46%-4.59%-30.34%+41.35% 97.14B
Weighted average by Cap. -0.60%-5.48%-38.55%+35.18%

Financials

2026 *2027 *
Net sales 660M 765M 625M 566M 1.06B 73.13B 1.07B 7.42B 2.85B 37.21B 2.87B 2.81B 118B 684M 794M 648M 587M 1.1B 75.85B 1.11B 7.69B 2.96B 38.59B 2.98B 2.92B 122B
Net income 21.3M 24.72M 20.17M 18.28M 34.3M 2.36B 34.47M 240M 92.11M 1.2B 92.84M 90.81M 3.8B 28M 32.5M 26.51M 24.03M 45.08M 3.1B 45.31M 315M 121M 1.58B 122M 119M 4.99B
Net Debt 162M 188M 154M 139M 261M 17.98B 262M 1.82B 701M 9.15B 707M 691M 28.9B 134M 155M 127M 115M 215M 14.83B 216M 1.5B 578M 7.55B 583M 570M 23.84B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
11/09/26 €10.32 0.00% 2,782
10/09/26 €10.32 0.00% 22,725
09/09/26 €10.32 +0.39% 14,785
08/09/26 €10.28 -0.77% 3,418
07/09/26 €10.36 +0.19% 1,856
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.32EUR
Average target price
15.50EUR
Spread / Average Target
+50.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCGM Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!